A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status

NCT03665402 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Drug-Induced Liver Injury
Adverse Drug Event

Interventions

DRUG: Isoniazid

Sponsor

Seoul National University Hospital

Collaborators

[object Object]